跳至主要内容
临床试验/IRCT20221227056943N1
IRCT20221227056943N1招募中4 期

Dextromethorphan augmentation therapy for moderate-to-severe obsessive–compulsive disorder: randomized, double-blind,placebo-controlled trial

Zanjan University of Medical Sciences0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients diagnosed with obsessive-compulsive disorder with moderate to high severity (YBOCS>16)
  • Patients who have not responded to 12 weeks of obsessive-compulsive disorder treatment with an adequate dose of an SSRI
  • People over 18 years old
  • People who have filled out informed consent

排除标准

  • Comorbidity with other psychiatric disorders except major depressive disorder, including psychotic disorders, substance dependence disorders
  • Severe kidney and liver disease
  • Unstable medical condition

研究者

相似试验

Dextromethorphan augmentation therapy for obsessive... | 临床试验